Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4HUN7
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 1 |
GO:0032259 | methylation | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008168 | methyltransferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.447 |
CLV_PCSK_PC1ET2_1 | 174 | 176 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 83 | 85 | PF00082 | 0.270 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.497 |
DEG_MDM2_SWIB_1 | 155 | 162 | PF02201 | 0.445 |
DOC_CYCLIN_yCln2_LP_2 | 148 | 154 | PF00134 | 0.411 |
DOC_MAPK_gen_1 | 160 | 170 | PF00069 | 0.383 |
DOC_MAPK_MEF2A_6 | 163 | 172 | PF00069 | 0.399 |
DOC_MAPK_MEF2A_6 | 7 | 16 | PF00069 | 0.465 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.386 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.529 |
DOC_WW_Pin1_4 | 82 | 87 | PF00397 | 0.445 |
LIG_14-3-3_CanoR_1 | 220 | 229 | PF00244 | 0.520 |
LIG_BRCT_BRCA1_1 | 31 | 35 | PF00533 | 0.409 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.411 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.411 |
LIG_FHA_1 | 217 | 223 | PF00498 | 0.548 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.411 |
LIG_LIR_Apic_2 | 119 | 124 | PF02991 | 0.405 |
LIG_LIR_Gen_1 | 133 | 144 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 200 | 211 | PF02991 | 0.373 |
LIG_LIR_Gen_1 | 237 | 246 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 60 | 71 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 76 | 82 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 116 | 121 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 153 | 158 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 200 | 206 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 237 | 242 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 76 | 80 | PF02991 | 0.342 |
LIG_Pex14_2 | 155 | 159 | PF04695 | 0.445 |
LIG_PTB_Apo_2 | 182 | 189 | PF02174 | 0.411 |
LIG_PTB_Phospho_1 | 182 | 188 | PF10480 | 0.411 |
LIG_SH2_CRK | 136 | 140 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 111 | 115 | PF00017 | 0.369 |
LIG_SH2_STAP1 | 63 | 67 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.393 |
LIG_SH3_1 | 83 | 89 | PF00018 | 0.380 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.427 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.380 |
LIG_SH3_5 | 73 | 77 | PF00018 | 0.445 |
LIG_SUMO_SIM_anti_2 | 225 | 230 | PF11976 | 0.375 |
LIG_SUMO_SIM_par_1 | 167 | 173 | PF11976 | 0.399 |
LIG_TRAF2_1 | 44 | 47 | PF00917 | 0.527 |
MOD_CK1_1 | 209 | 215 | PF00069 | 0.524 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.411 |
MOD_CK2_1 | 209 | 215 | PF00069 | 0.490 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.516 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.393 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.507 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.522 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.467 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.511 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.474 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.538 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.389 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.509 |
MOD_N-GLC_2 | 4 | 6 | PF02516 | 0.511 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.466 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.377 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.520 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.526 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.270 |
MOD_NEK2_2 | 12 | 17 | PF00069 | 0.523 |
MOD_Plk_1 | 124 | 130 | PF00069 | 0.354 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.577 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.445 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.259 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.526 |
MOD_ProDKin_1 | 82 | 88 | PF00069 | 0.445 |
MOD_SUMO_rev_2 | 43 | 50 | PF00179 | 0.494 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.496 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.411 |
TRG_ER_FFAT_2 | 133 | 143 | PF00635 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDF1 | Leptomonas seymouri | 61% | 99% |
A0A3S7WRE9 | Leishmania donovani | 100% | 79% |
A4H6B4 | Leishmania braziliensis | 72% | 100% |
E9ACR1 | Leishmania major | 91% | 100% |
E9AND6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |